Table 1.
Variable | Number of cases (N = 1,431) |
---|---|
Age at diagnosis (years) | |
<50 |
780 |
50 to 69 |
572 |
≥70 |
79 |
Neoadjuvant chemotherapy received | |
No |
1,075 |
Yes |
356 |
Comorbidities | |
None |
1,024 |
One or more |
407 |
Menopausal status | |
Premenopause |
703 |
Menopause |
728 |
Residential status | |
Rural |
453 |
Urban |
978 |
Smoking | |
Previous or current |
13 |
Never or no report |
1,418 |
Reasons for visit | |
Self-examination |
1,404 |
Physical examination |
27 |
Tumor size | |
≤2 |
1,088 |
>2 |
214 |
Lymph node metastasis | |
Negative |
823 |
Positive |
606 |
Distant metastasis | |
Negative |
1,421 |
Positive |
10 |
Tumor stage | |
I |
178 |
II |
927 |
III |
198 |
IV |
10 |
Hormone receptor status |
|
ER- and PR- |
203 |
ER + and/or PR+ |
648 |
Histological type |
|
IDC |
1,164 |
ILC |
49 |
Others |
218 |
Procedure |
|
Radical mastectomy |
503 |
Modified radical mastectomy |
828 |
Breast/nipple conserving surgery |
55 |
NOS |
45 |
Treatment |
|
Surgery |
1,431 |
Radiotherapy |
11 |
Endocrinotherapy |
264 |
Chemotherapy |
936 |
NOS | 496 |
ER, estrogen receptor; PR, progestogen receptor; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; NOS, not otherwise specified.